Pros and cons of different therapeutic antibody formats for recombinant antivenom development.

View / Open Files

Published version (PDF, 2Mb)

Accepted version (PDF, 3Mb)

Authors

  Laustsen, Andreas H

María Gutiérrez, José

  Knudsen, Cecilie

  Johansen, Kristoffer

  Bermúdez-Méndez, Erick

Cerni, Felipe A

  Jürgensen, Jonas A

Ledsgaard, Line

Martos-Esteban, Andrea

Øhlenschlæger, Mia

Pus, Urska

  Andersen, Mikael R

Lomonte, Bruno

Engmark, Mikael

Pucca, Manuela B

Show moreShow less

Publication Date

2018-05

Journal Title

Toxicon : official journal of the International Society on Toxinology

ISSN

0041-0101

Volume

146

Pages

151-175

Language

eng

Type

Article

This Version

VoR

Physical Medium

Print-Electronic

Metadata

Show full item record

Citation

Laustsen, A. H., María Gutiérrez, J., Knudsen, C., Johansen, K., Bermúdez-Méndez, E., Cerni, F. A., Jürgensen, J. A., et al. (2018). Pros and cons of different therapeutic antibody formats for recombinant antivenom development.. Toxicon : official journal of the International Society on Toxinology, 146 151-175. https://doi.org/10.1016/j.toxicon.2018.03.004

Keywords

Venoms, Animals, Humans, Recombinant Proteins, Antivenins, Antibodies, Camelus

Embargo Lift Date

2100-01-01

Identifiers

External DOI: https://doi.org/10.1016/j.toxicon.2018.03.004

This record's URL: https://www.repository.cam.ac.uk/handle/1810/277227



Rights

Attribution 4.0 International

Licence URL: http://creativecommons.org/licenses/by/4.0/